1PO2

POLIOVIRUS (TYPE 1, MAHONEY) IN COMPLEX WITH R77975, AN INHIBITOR OF VIRAL REPLICATION


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.9 Å
  • R-Value Work: 0.249 

wwPDB Validation 3D Report Full Report


This is version 1.3 of the entry. See complete history

Literature

Ligand-induced conformational changes in poliovirus-antiviral drug complexes.

Hiremath, C.N.Filman, D.J.Grant, R.A.Hogle, J.M.

(1997) Acta Crystallogr.,Sect.D 53: 558-570

  • DOI: 10.1107/S0907444997000954
  • Primary Citation of Related Structures:  1PO1

  • PubMed Abstract: 
  • Crystal structures of the Mahoney strain of type 1 poliovirus complexed with the antiviral compounds R80633 and R77975 were determined at 2.9 A resolution. These compounds block infection by preventing conformational changes required for viral uncoat ...

    Crystal structures of the Mahoney strain of type 1 poliovirus complexed with the antiviral compounds R80633 and R77975 were determined at 2.9 A resolution. These compounds block infection by preventing conformational changes required for viral uncoating. In various drug-poliovirus complexes reported earlier, no significant conformational changes were found in the structures of the capsid proteins. In the structures reported here, the strain of virus is relatively insensitive to these antivirals. Correspondingly, significant conformational changes are necessary to accommodate the drug. These conformational changes affect both the immediate vicinity of the drug binding site, and more distant loops located near the fivefold axis. In addition, small but concerted shifts of the centers of mass of the major capsid proteins consistently have been detected whose magnitudes are correlated inversely with the effectiveness of the drugs. Collectively, the drug complexes appear to sample the conformational repertoire of poliovirus near equilibrium, and thus provide a possible model for the earliest stages of viral uncoating during infection.


    Related Citations: 
    • Binding of the Antiviral Drug Win51711 to the Sabin Strain of Type 3 Poliovirus: Structural Comparison with Drug Binding in Rhinovirus 14
      Hiremath, C.N.,Grant, R.A.,Filman, D.J.,Hogle, J.M.
      (1995) Acta Crystallogr.,Sect.D 51: 473
    • The Nucleotide Sequence of Poliovirus Type 3 Leon 12 A1B: Comparison with Poliovirus Type 1
      Stanway, G.,Cann, A.J.,Hauptmann, R.,Hughes, P.,Clarke, L.D.,Mountford, R.C.,Minor, P.D.,Schild, G.C.,Almond, J.W.
      (1983) Nucleic Acids Res. 11: 5629
    • Structural Factors that Control Conformational Transitions and Serotype Specificity in Type 3 Poliovirus
      Filman, D.J.,Syed, R.,Chow, M.,Macadam, A.J.,Minor, P.D.,Hogle, J.M.
      (1989) Embo J. 8: 1567
    • Three-Dimensional Structure of Poliovirus at 2.9 A Resolution
      Hogle, J.M.,Chow, M.,Filman, D.J.
      (1985) Science 229: 1358
    • Myristylation of Picornavirus Capsid Protein Vp4 and its Structural Significance
      Chow, M.,Newman, J.F.,Filman, D.,Hogle, J.M.,Rowlands, D.J.,Brown, F.
      (1987) Nature 327: 482
    • Structures of Poliovirus Complexes with Anti-Viral Drugs: Implications for Viral Stability and Drug Design
      Grant, R.A.,Hiremath, C.N.,Filman, D.J.,Syed, R.,Andries, K.,Hogle, J.M.
      (1994) Curr.Biol. 4: 784
    • Role of Conformational Transitions in Poliovirus Assembly and Cell Entry
      Hogle, J.M.,Syed, R.,Fricks, C.E.,Icenogle, J.P.,Flore, O.,Filman, D.J.
      (1990) New Aspects of Positive-Strand RNA Viruses --: 199


    Organizational Affiliation

    Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
POLIOVIRUS TYPE 1 MAHONEY
0
5N/AN/A
Protein Feature View is not available: No corresponding UniProt sequence found.
Entity ID: 2
MoleculeChainsSequence LengthOrganismDetails
POLIOVIRUS TYPE 1 MAHONEY
1
302Poliovirus type 1 (strain Mahoney)EC: 3.6.1.15, 3.4.22.28, 3.4.22.29, 2.7.7.48
Find proteins for P03300 (Poliovirus type 1 (strain Mahoney))
Go to UniProtKB:  P03300
Entity ID: 3
MoleculeChainsSequence LengthOrganismDetails
POLIOVIRUS TYPE 1 MAHONEY
2
272Poliovirus type 1 (strain Mahoney)EC: 3.6.1.15, 3.4.22.28, 3.4.22.29, 2.7.7.48
Find proteins for P03300 (Poliovirus type 1 (strain Mahoney))
Go to UniProtKB:  P03300
Entity ID: 4
MoleculeChainsSequence LengthOrganismDetails
POLIOVIRUS TYPE 1 MAHONEY
3
238Poliovirus type 1 (strain Mahoney)EC: 3.6.1.15, 3.4.22.28, 3.4.22.29, 2.7.7.48
Find proteins for P03300 (Poliovirus type 1 (strain Mahoney))
Go to UniProtKB:  P03300
Entity ID: 5
MoleculeChainsSequence LengthOrganismDetails
POLIOVIRUS TYPE 1 MAHONEY
4
68Poliovirus type 1 (strain Mahoney)EC: 3.6.1.15, 3.4.22.28, 3.4.22.29, 2.7.7.48
Find proteins for P03300 (Poliovirus type 1 (strain Mahoney))
Go to UniProtKB:  P03300
Small Molecules
Ligands 2 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
MYR
Query on MYR

Download SDF File 
Download CCD File 
4
MYRISTIC ACID
C14 H28 O2
TUNFSRHWOTWDNC-UHFFFAOYSA-N
 Ligand Interaction
J77
Query on J77

Download SDF File 
Download CCD File 
1
(METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE
R77975
C21 H27 N3 O3
KCHIOGFOPPOUJC-UHFFFAOYSA-N
 Ligand Interaction
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.9 Å
  • R-Value Work: 0.249 
  • Space Group: P 21 21 2
Unit Cell:
Length (Å)Angle (°)
a = 322.940α = 90.00
b = 358.040β = 90.00
c = 380.150γ = 90.00
Software Package:
Software NamePurpose
X-PLORrefinement
X-PLORmodel building
X-PLORphasing

Structure Validation

View Full Validation Report or Ramachandran Plots



Entry History 

Deposition Data

Revision History 

  • Version 1.0: 1997-12-03
    Type: Initial release
  • Version 1.1: 2008-03-24
    Type: Version format compliance
  • Version 1.2: 2011-07-13
    Type: Source and taxonomy, Version format compliance
  • Version 1.3: 2017-11-29
    Type: Derived calculations, Other